维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Shord SS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Gemcitabine pharmacokinetics and interaction with advanced non - small -cell lung cancer显示文摘	Shord SS Faucette SR Gillenwateer HH	2003	Cancer Chemother Pharmacol2003，51，4：	1
2	Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines显示文摘	Shord SS Patel SR	2009	J Exp Clin Cancer Res2009，28，3：	1
3	Gemc itabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer 显示文摘	Faucette SR Gillenwater HH	2003	Cancer Chemother Pharmacol2003，51，4：	1
4	Gemcitabinepharmacokinetics and interaction with paclitaxel in patients withadvanced non- small- cell lung cancer显示文摘	Fancette SR Gillenwater HH	2003	Cancer ChemotherPharmacol2003，51，：	1
5	Oxaliplatin biotransformation and pharmacokinetics:a pilot study to determine the possible relationship to neurotoxicity显示文摘	Shord SS Bernard SA Lindley C	2002	Anticancer Res2002，22，4：	1
6	Single-dose rasburicase for tumour lysis syndrome in adults:weight-based approach显示文摘	Campara M Shord SS Haaf CM	2009	J Clin Pharm Ther2009，34，2：	1
7	Epigenetics and oncology显示文摘	Mummaneni P Shord SS	2014	Pharmacotherapy2014，34，5：	1
8	Gemcitabine pharmacekinetics and interaction with paclitaxel in patients with advanced non-small cell lung cancer显示文摘	Shord SS Faucette SR GiUenwater HH	2003	Cancer Chemother Pharmacol2003，51，4：	1
9	Gemcitabine pharmacoki- netics and interaction with paclitaxel in patients with advanced non-smaU cell lung cancer 显示文摘	Shord SS Fancette SR Gillenwater HH	2003	Cancer Chemother Pharmacol2003，51，4：	1
10	Oxaliplatin biotransformation and pharmacokinetics:a pilot study to determine the possible relationship to neurotoxicity显示文摘	Shord SS Bernard SA Lindley C	2002	Anticancer Res2002，22，4：	1
11	Cemcitabine phanna-cokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer显示文摘	Shord SS Faucette SR Gillenwater HH	2003	Cancer Chemother Pharmacol2003，51，4：	1
12	Gemcitabine pharmacoki- netics and interaction with paclitaxel in patients with advanced non- small-cell lung cancer 显示文摘	Shord SS Fancctte SR Gillenwater HH	2003	Cancer Chemother Pharmaco12003，51，：	1
13	Understanding and man- aging the possible adverse effects associated with bevacizumab显示文摘	Shord SS Bressler LR Tierney LA	2009	AmJ Health Syst Pharm2009，66，11：	1
14	Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer显示文摘	Shord SS Faucette SR Gillenwater HH	2003	Cancer Chemother Pharmacol2003，51，4：	1
15	Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer 显示文摘	Shord SS Faucette SR Gillenwater HH	2003	Cancer Chemother Pharmacol2003，51，4：	1
16	Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals显示文摘	Shord SS Shah K Lukose A	2009	Integr Cancer Ther2009，8，3：	1
17	Understanding and managing the possible adverse effects associated with bevacizumab显示文摘	Shord SS Bressler LR Tierney LA		0，，11：	1
18	Optimizing chemotherapy: Con- comitant medication lists显示文摘	Hanigan MH Cruz BL Shord SS	2011	Clin Pharmacol Ther2011，89，：	1
19	Oxaliplatin bio- transformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity 显示文摘	Shord SS Bernard SA Lindley C	2002	Anticancer Res2002，22，4：	1
20	Oxaliplatin biotransformation and pharmacokinetics:a pilot study to determine the possible relationship to neurotoxicity显示文摘	Shord SS Bernard SA Lindley C		0，，04：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示